Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 09, 2024 09:00 ET | Source: Movellus

Tenstorrent and Movellus Form Strategic Engagement for Next-Generation Chiplet-Based AI and HPC Solutions

Movellus and Tenstorrent announced that Tenstorrent has licensed Movellus’ digital IP family as part of a strategic engagement, for its AI and HPC chiplets
September 09, 2024 08:30 ET | Source: Femasys Inc.

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

ATLANTA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
September 04, 2024 07:30 ET | Source: iRhythm

iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
September 04, 2024 07:30 ET | Source: Psyence Biomedical Ltd.

Psyence Biomed Announces Worldwide Exclusive Licensing Agreement with PsyLabs to Supply Nature-Derived Psilocybin to be Evaluated as a Potential Treatment for Alcohol Use Disorder (AUD) and Other Substance Use Disorders (SUDs)

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM, PBMWW) (“Psyence Biomed” or the “Company”) today announced that the Company has entered into a worldwide, exclusive...
September 03, 2024 21:00 ET | Source: Shanghai EpimAb Biotherapeutics Co., Ltd.

EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody

SHANGHAI and SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, Inc. (“EpimAb” or “EpimAb Biotherapeutics”) a clinical stage biopharmaceutical company specializing in the...
September 03, 2024 06:00 ET | Source: LanzaTech Inc.

LanzaTech Signs Master License Agreement with SEKISUI to Develop Multiple Commercial Scale Waste-to-Ethanol Plants Across Japan

LanzaTech progresses partnership with SEKISUI by formalizing commercial framework to construct facilities which significantly advance how municipalities...
August 29, 2024 18:53 ET | Source: Emergent BioSolutions

Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions

GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics...
August 29, 2024 10:00 ET | Source: Finwave Semiconductor

Finwave Semiconductor and GlobalFoundries Partner on RF GaN-on-Si Technology for Cellular Handset Applications

Finwave Semiconductor and GlobalFoundries partner on RF GaN-on-Si technology for cellular handset applications
August 28, 2024 13:24 ET | Source: KuicK Research

Bispecific Trispecific Tetraspecific Multispecific Antibodies Market Size Clinical Trials Approved Antibody Sales Price Insight Antibodies Market By Region Indication Companies

Delhi, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Global Multispecific Antibodies Market, Drug Sales, Price and Clinical Trials Insight 2029 Report Highlights: Global and Regional Market AnalysisGlobal...
August 27, 2024 08:30 ET | Source: E.C.D. Automotive Design

ECD Auto Design Adds Blackbridge Motors Defenders to Product Lineup

KISSIMMEE, Fla., Aug. 27, 2024 (GLOBE NEWSWIRE) -- ECD Automotive Design, Inc. (Nasdaq:ECDA) (“ECDA” or the “Company”), an industry leader in delivering restored, modified and electrified Land Rover...